Home
Price T Rowe Associates reported a 3.1% stake in Repligen RGEN · 1,751,887 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 3.1%
- Last report
- 8.2% · filed 26/02/17
- Shares held
- 1,751,887 sh
- Class
- COMMON STOCK
- Stock
- Repligen RGEN
- Holder
- Price T Rowe Associates
- Event date
- 26/06/30
- Filed
- 26/08/14
3.1% stake · below 5%
- Stake
- 3.1%
- Last report
- 8.2%
- Since last report
- −5.1pp
Repligen trades, last 26 weeks
What else happened in Repligen around then
Filed or reported within 30 days of the trade day · 05/31~07/30Price T Rowe Associates's other 5% stake reports
- Price T Rowe Associates
5% stake10x Genomics
5% stake10x Genomics
TXG
11.7% stake
14,044,020 sh
11.7% stake
Filed 09/08
- Price T Rowe Associates
5% stakePerrigo
5% stakePerrigo
PRGO
0.1% stake
231,010 sh
0.1% stake
Filed 09/08
- Price T Rowe Associates
5% stakeVicor
5% stakeVicor
VICR
12.8% stake
4,384,882 sh
12.8% stake
Filed 09/08
- Price T Rowe Associates
5% stakeKymera Therapeutics
5% stakeKymera Therapeutics
KYMR
10.7% stake
8,873,588 sh
10.7% stake
Filed 09/08
- Price T Rowe Associates
5% stakeMidera Food Processing
5% stakeMidera Food Processing
MFP
8.7% stake
3,940,556 sh
8.7% stake
Filed 09/08
